mazdaki
Long

CERS- There is substantial Market for PI Platelets

NASDAQ:CERS   CERUS CORP
17 2 0
with serial FDA approvals, there will be institutional buyers accumulating this stock . Started an initial position and will add on weakness.
mazdaki PRO
2 years ago
will reduce position in the 15-20 range.
Reply
mazdaki PRO
2 years ago
adding on at this point the move down so far should weed out weak hands. Cupand handle formation.
Reply
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out